Hepatitis B Virus Vaccine
Mixed Anxiety And Depressive Disorder
Eunice DubevaccinePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the Mixed Anxiety And Depressive Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Tenofovir Disoproxil Fumarate Azienda Ospedaliera San Gerardo di Monza | Phase 4 | BB |
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Massachusetts General Hospital | Phase 4 | BB |
(±)-Ftc Azienda Ospedaliera San Gerardo di Monza | Phase 4 | BB |
Azithromycin University of California, San Francisco | Phase 4 | BB |
Gardasil 9 Vaccine Eunice Dube | Phase 4 | BB |
View all 19 →
Same molecule, other indications
Hepatitis B Virus Vaccine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →